Added to YB: 2025-12-12
Pitch date: 2025-10-20
PRPH [bullish]
ProPhase Labs, Inc.
-77.87%
current return
Author Info
No bio for this author
Company Info
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States.
Market Cap
$6.9M
Pitch Price
$0.51
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.62
P/E
-0.11
EV/Sales
2.80
Sector
Pharmaceuticals
Category
special_situation
ProPhase Labs, Inc. - $PRPH
PRPH: Multi-segment health co pursuing $50M COVID testing receivables (3x mkt cap) via Crown Medical contingency collections; bankruptcy court filing to accelerate settlements. BE-Smart esophageal cancer test patent granted, targets $28B market. Crypto treasury strategy in development with major partners. Vote needed on 1B share authorization for institutional partnerships.
Read full article (38 min)